New technology could aid in development of less-painful subcutaneous biologic administration
“We created the platform to provide new information to drug makers to help them better understand the amount of pain a certain injectable me
top of page
By John Evans
- Jan 10, 2020
- 2 min
Nrp1 a potential new target for psoriasis Tx
“These data demonstrate the therapeutic benefit of blocking Vegfa/Nrp1 interaction in the treatment of psoriatic disease, which may be safer
By John Evans
- Nov 15, 2019
- 2 min
More effective rituximab dosing for pemphigus identified
“This is the first study to provide evidence for physicians to justify a lymphoma-dose regimen of rituximab when treating their patients wit
by Cory Perla
- May 16, 2019
- 1 min
Largest of Its Kind Study Examines Safety of Systemic Treatments for Patients With Psoriasis
A large new study has evaluated the risk of infection associated with various biologic therapies for patients with psoriasis finding that th
Featured Posts
bottom of page